Table: Solasia Pharma -2021 group forecast(IFRS)
Nov 10 (Reuters) -
Solasia Pharma K. K.
CONSOLIDATED EARNINGS ESTIMATES
(in billions of yen unless specified)
Full Year to Full Year to
Dec 31, 2021 Dec 31, 2021
LATEST PREVIOUS
FORECAST FORECAST
Sales 600 mln
Operating loss 2.50
PreTax loss 2.50
Net loss 2.50
EPS Basic loss 18.73 yen
NOTE - Solasia Pharma K. K..(Figures are reported based on international accounting rules (IFRS).)
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4597.T